Abstract

The aim of the present study was to evaluate the effect of leucine treatment (0.30 mM) on muscle weight and signaling of myoproteins related to synthesis and degradation pathways of soleus muscle following seven days of complete sciatic nerve lesion. Wistar rats (n = 24) of 3–4 months of age (192 ± 23 g) were used. The animals were randomly distributed into four experimental groups (n = 6/group): control, treated with leucine (L), denervated (D) and denervated treated with leucine (DL). Dependent measures were proteins levels of AKT, AMPK, mTOR, and ACC performed by Western blot. Leucine induced a reduction in the phosphorylation of AMPK (p < 0.05) by 16% in the L and by 68% in the DL groups as compared with control group. Denervation increased AMPK by 24% in the D group as compared with the control group (p < 0.05). AKT was also modulated by denervation and leucine treatment, highlighted by the elevation of AKT phosphorylation in the D (65%), L (98%) and DL (146%) groups as compared with the control group (p < 0.05). AKT phosphorylation was 49% higher in the D group as compared with the DL group. Furthermore, denervation decreased mTOR phosphorylation by 29% in the D group as compared with the control group. However, leucine treatment induced an increase of 49% in the phosphorylation of mTOR in the L group as compared with the control group, and an increase of 154% in the DL as compared with the D group (p < 0.05). ACC phosphorylation was 20% greater in the D group than the control group. Furthermore, ACC in the soleus was 22% lower in the in the L group and 50% lower in the DL group than the respective control group (p < 0.05). In conclusion, leucine treatment minimized the deleterious effects of denervation on rat soleus muscle by increasing anabolic (AKT and mTOR) and decreasing catabolic (AMPK) pathways. These results may be interesting for muscle recovery following acute denervation, which may contribute to musculoskeletal rehabilitation after denervation.

Highlights

  • Peripheral nerve injuries are commonly present during clinical practice of orthopedics and traumatology,in which alterations of the functional pattern of peripheral and central nervous system are accompanied by muscle tissue disuse

  • These findings suggest that branched-chain amino acids (BCAAs) may protect against muscle atrophy by inhibiting protein breakdown as well as protein synthesis

  • There were group × time interactions showing that denervation and leucine treatment interact with muscle weight (p < 0.05)

Read more

Summary

Introduction

Peripheral nerve injuries are commonly present during clinical practice of orthopedics and traumatology,in which alterations of the functional pattern of peripheral and central nervous system are accompanied by muscle tissue disuse. Skeletal muscle undergoes in a harmful nutrition status with modification of acetyl-CoA carboxylase (ACC) activity (Han et al, 2007), as well as a peripheral insulin resistance due to the decrease of phosphatidylinositol 3-kinase (PI3K) levels, which is linked to the insulin receptor and the reduction of glucose transporters (GLUTs). This process results in the decrease of energetic reserves and muscle proteolysis (Coderre et al, 1992; Bodine et al, 2001; Salvini et al, 2012; Bonaldo and Sandri, 2013). The divergent response in size and functional MHC I soleus properties with the concurrent exercise program was a unique finding further highlighting the challenges of protecting the unloaded soleus, maintaing MHC power but not size and strength (Trappe et al, 2008). Mounier et al (2009) demonstrate that the nutrition of proteins and BCAAs countermeasure was efficient against slow fiber atrophy assessed by western blotting and force of single skinned fibers after a 60-day bed rest

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call